A detailed history of Susquehanna International Group, LLP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 32,707 shares of CRL stock, worth $6.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32,707
Previous 16,645 96.5%
Holding current value
$6.4 Million
Previous $3.44 Million 87.38%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$187.96 - $245.29 $3.02 Million - $3.94 Million
16,062 Added 96.5%
32,707 $6.44 Million
Q2 2024

Aug 15, 2024

SELL
$206.39 - $268.73 $82,556 - $107,492
-400 Reduced 2.35%
16,645 $3.44 Million
Q1 2024

May 07, 2024

BUY
$203.52 - $273.43 $118,855 - $159,683
584 Added 3.55%
17,045 $4.62 Million
Q4 2023

Feb 14, 2024

SELL
$164.52 - $238.84 $7.16 Million - $10.4 Million
-43,528 Reduced 72.56%
16,461 $3.89 Million
Q3 2023

Nov 14, 2023

BUY
$194.44 - $217.61 $4.16 Million - $4.66 Million
21,416 Added 55.52%
59,989 $11.8 Million
Q2 2023

Aug 11, 2023

BUY
$183.71 - $210.25 $2.35 Million - $2.69 Million
12,804 Added 49.69%
38,573 $8.11 Million
Q1 2023

May 16, 2023

BUY
$191.89 - $259.92 $1.26 Million - $1.7 Million
6,555 Added 34.12%
25,769 $5.2 Million
Q4 2022

Feb 14, 2023

BUY
$197.11 - $250.07 $3.57 Million - $4.53 Million
18,132 Added 1675.79%
19,214 $4.19 Million
Q3 2022

Nov 14, 2022

SELL
$182.44 - $250.54 $7.77 Million - $10.7 Million
-42,613 Reduced 97.52%
1,082 $213,000
Q2 2022

Aug 15, 2022

BUY
$204.13 - $302.4 $3.47 Million - $5.15 Million
17,016 Added 63.78%
43,695 $9.35 Million
Q1 2022

May 16, 2022

SELL
$255.51 - $362.11 $2.19 Million - $3.1 Million
-8,564 Reduced 24.3%
26,679 $7.58 Million
Q4 2021

Feb 14, 2022

BUY
$351.38 - $448.68 $4.65 Million - $5.94 Million
13,231 Added 60.11%
35,243 $13.3 Million
Q3 2021

Nov 15, 2021

SELL
$372.64 - $458.3 $35,773 - $43,996
-96 Reduced 0.43%
22,012 $9.08 Million
Q2 2021

Aug 11, 2021

BUY
$294.17 - $371.65 $2.84 Million - $3.59 Million
9,658 Added 77.57%
22,108 $8.18 Million
Q1 2021

May 17, 2021

BUY
$249.67 - $299.48 $2.39 Million - $2.86 Million
9,566 Added 331.69%
12,450 $3.61 Million
Q4 2020

Feb 16, 2021

SELL
$222.0 - $252.62 $192,696 - $219,274
-868 Reduced 23.13%
2,884 $721,000
Q3 2020

Nov 16, 2020

BUY
$175.56 - $226.45 $213,305 - $275,136
1,215 Added 47.89%
3,752 $850,000
Q2 2020

Aug 14, 2020

SELL
$118.84 - $189.72 $2.37 Million - $3.78 Million
-19,950 Reduced 88.72%
2,537 $442,000
Q1 2020

May 15, 2020

BUY
$98.9 - $178.34 $1.83 Million - $3.29 Million
18,465 Added 459.1%
22,487 $2.84 Million
Q4 2019

Feb 14, 2020

SELL
$126.05 - $152.76 $1.33 Million - $1.61 Million
-10,569 Reduced 72.44%
4,022 $614,000
Q2 2019

Aug 16, 2019

BUY
$123.4 - $148.55 $1.17 Million - $1.4 Million
9,454 Added 184.04%
14,591 $2.07 Million
Q2 2019

Aug 14, 2019

BUY
$123.4 - $148.55 $633,905 - $763,101
5,137 New
5,137 $729,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.